Chymosin is considered the main enzyme in milk industry since it is used for commercial production of cheese. Conventional animal chymosin production losses large numbers of unweaned calves which affect on the animal wealth. In order to reduce the manufacturing cost, recombinant production of chymosin is the good choice. In the current study, camel pro-chymosin gene (1101 bp) was in vitro synthesized and cloned into pASG-vector. The obtained plasmid pASG_pro.chym was transformed into the bacteria E. coli BL21(DE3). The bacterial system expressed pro-chymosin under control with tet-promoter and it was able to produce approximately 260 mg/L of recombinant enzyme under lab scale. The SDS-PAGE showed that the zymogen protein (367 amino acids residues long) has a molecular weight of 40.6 kDa, while the active form (323 amino acids residues long) has a molecular weight of 35.6 kDa. The recombinant pro-chymosin is presented in inclusion bodies and it is solubilized in 4-8 M urea. After solubilization and renaturation, recombinant pro-chymosin was subjected to a low pH and it was converted into mature active chymosin. The optimum milk clotting conditions were a pH of 5.75, temperature of 50-55 °C, and 15 mM of CaCl 2 . It can be concluded that the obtained recombinant chymosin from E. coli is suitable for commercial cheese production.
INTRODUCTION
Chymosin (EC 3.4.23.4) , an aspartyl protease, is found in mucosal cells of the fourth stomach of unweaned calves (Williams et al., 1997) . The enzyme is responsible for partial proteolysis of κ-casein and it attacks the peptide bonds between the amino acids Phe 105 and Met 106 which destabilized casein micelles resulting in clotting milk (Albert et al., 1998) . So, it is the main additives in cheese manufacturing. Many microorganisms such as Rhizomucor miehei (Gray et al., 1986) and R. Pusillus (Baudys et al., 1988) produce rennet-like proteases that can replace the calf rennet. However, to produce high quality cheese, animal rennet enzyme (chymosin) is considered to be better choice than plant and microbial rennet which characterized by their un-specific hydrolysis of casein producing un-favourable flavour and taste as well as reducing the cheese yield (Kumar et al., 2010) . For that, animal chymosin, especially bovine chymosin, is widely used in dairy industries for cheese production (Mohanty et al., 1999) . However, traditional preparation of bovine chymosin requires slaughter of large number of unweaned calves with high price which lead to affect on national economy. Also, the extraction and purification is time consuming and its expose for deterioration agents is high (Starovoitova et al., 2006) . So, biologists solve this problem by recombinant producing mammalian chymosin to provide the enzyme requirement in cheese industries. Currently, recombinant chymosin is used for one-third of the cheese production over the world (Starovoitova et al., 2006 and El-Sohaimy et al., 2010) .
The calf chymosin gene was among the first mammalian genes that were cloned in different microorganism. Using recombinant DNA technology, calf chymosin encoding gene was expressed in GRAS (Generally Recognized As Safe) microorganisms as bacteria (Nishimori et al., 1982; Emtage et al., 1983; ElSohaimy et al., 2010; Menzella, 2011 and Noseda et al., 2016) , yeast (Mohanty et al., 1999; Starovoitova et al., 2006; Zhang et al., 2009; Noseda et al., 2013; Wang et al., 2015 and Noseda et al., 2016) , filamentous fungus (Cardoza et al., 2003 and Sharma et al., 2009 ), and plant (van Rooijen et al., 2008 .
First approach was made by cloning of full-length cDNA of the mRNA and their sequence has been determined (Nishimori et al., 1982) . The precursor protein, pre-pro-chymosin, has a 16 amino acids signal peptide that was corresponding on transfer the zymogen pro-chymosin into stomach which is further activated by removal of the pro-peptide, the 42-amino acids from the NH 2 -terminus (Emtage et al., 1983) . Expression of the pro-chymosin in yeast or fungus resulting on production of the enzyme in an active form. While, expression of the pro-enzyme in E. coli exit as insoluble form which needs further solubilization and renaturation of the enzyme from the inclusion bodies (Mule et al., 2009 and El-Sohaimy et al., 2010) . The major benefit of this insoluble form that it makes purification and activation could be achieved since most of E. coli proteins (about 90%) are precipitated under the acidic condition which is used to activate the pro-chymosin (Rodríguez-Carmona, 2010) . Therefore, several approaches have been developed for optimizing the solubilization and renaturation process to reduce the process cost as well as increase the yield of the mature active chymosin (Koritzinsky et al., 2013) . The enzymatic characteristics of E. coli recombinant chymosin are indistinguishable from those of native one (Starovoitova et al., 2006) .
Recently, recombinant camel chymosin attracts great interest in cheese industries because it produces cheese with good flavour and extended cheese shelf life (Langholm Jensen et al., 2013) . It has the ability to clot both camel's and cow's milk. In addition, it has 70% higher clotting activity, exhibits higher level of thermostability, and exhibits sevenfold higher clotting activity/proteolytic activity than bovine chymosin (Bansal et al., 2009 and Sorensen et al., 2011) .
Camel chymosin has been cloned and expressed firstly in Aspergillus niger (Kappeler et al., 2006) . The second group was expressed it in yeast Pichia pastoris with almost similar properties like the one produce by fungi (Wang et al., 2015) . However, expression of camel chymosin in E. coli has not been yet reported till now. In the current work, a full-length camel pro-chymosin gene was in vitro synthesized, introduced into E. coli BL21(DE3) strain via pASG-plasmid, and expressed under tet-promoter. The insoluble form of the pro-chymosin is further renaturation and activation. Also, the optimum clotting condition for the active camel chymosin was studied.
MATERIALS AND METHODS

Materials
The chemicals used in the current work were purchased from the following company, Sigma-Aldrich, IBA-lifesciences, and Takara. Oligonucleotides were purchased from Tsingke (China). The DNA purification kit, Phusion™ DNA polymerase, and restriction enzyme were purchased from Fermentas-GmbH (Fisher scientific, Schwerte, Germany). Strains, plasmids and primers.
Bacterial strains, empty vector, and constructed plasmids that were used in this work are presented in table (1). (Bryksin and Matsumura, 2010) in KanRvector (pEntry) using the oligonucleotides presented in table (2). Restriction site for the LguI restriction enzyme is: GCTCTTC,
The gene was divided into two fragments (Chym.P.1 and chyms.P.2) for accurate assembly. After assembly, the PCR products was cut with lguI and ligated with T4-ligase then it was transferred into E. coli DH5α with the general protocol (Chung et al., 1989) . The correct two plasmids (pE-chym.P.1 and pE-chym.P.2) were extracted and identified by cutting with restriction enzyme before sending for sequencing. Afterwards, the two plasmids were cut with Esp3I restriction enzyme and the two fragments were fused together and inserted in AmpR vector (pFusion). Then, the assembled fragment (1101 bp) was cloned in pEntry vector to produce pE-pro.chym and then sub-cloned into the expression vector (pASG.wt). The expression plasmid (pASG-pro.chym) was used for protein production.
Bacteria cultivation:
Escherichia coli DH5α and E. coli BL21 (DE3) cells were cultivated at 37
• C on lysogeny broth (LB) media supplemented with the appropriate antibiotics according to the demand (ampicillin 100 µg/ml or kanamycin 50 µg/ml). The required plasmids were transferred into chemically competent E. coli BL21 (DE3) or DH5α cells following the standard protocol (Chung et al., 1989) .
Gene expression and biomass production:
Pro-chymosin gene was expressed in E. coli BL21(DE3). Freshly transformed cells were plated on LBagar medium supplemented with (100 µg/mL Ampicillin) and one correct colony was expanded step-wise to yield final culture volume of 500 mL in LB-Medium (100 µg/mL Ampicillin). When the cells reached an OD 578 nm of about 0.4, the gene was expressed by adding the inducer (anhydrotetracycline, 200 ng/mL) for 2 hr at 37
• C. The induced cells were harvested by centrifugation at 6,000 g for 15 min, washed with Tris-buffer (50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 8.0) and stored at -80°C until used (Aboulnaga et al., 2013) .
Inclusion bodies purification:
Inclusion bodies purification was started with about one gram of wet cells. Cells were resuspended in 20 ml of lysis buffer (50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, 1 mg/ml lysozyme, pH 8.0) and incubated at 37
• C for 30 min. Then, the suspension was sonicated in an icewater bath using a Branson Sonifier with a duty cycle of 50% at 60% power for 10 min. The inclusion bodies were isolated from the mixture by centrifugation at 10,000 g for 20 min at room temperature. Clear supernatant was discarded and the pellet was washed twice with 50 ml of 10 mM EDTA, once with 0.5% triton X-100, and once with 20 mM phosphate buffer pH 7.5 (Rodríguez-Carmona, 2010).
Solubilization and renaturation of recombinant prochymosin:
Solubilization and renaturation has been done according to Menzella (2011) protocol with the following modification. Cleaned inclusion bodies were dissolved in solubilization buffer (50 mM KH 2 PO 4 , 8 M urea, pH 10.5). The solution was incubated at 30°C for 2 hr with continuous stirring, and then centrifuged at 10,000 g for 10 min to remove the insoluble molecules. The clear preparation was diluted with the renaturation buffer (50 mM KH 2 PO 4 , 0.5 M arginine, 10 µM CuSO 4 , pH 10.5) to have a final protein concentration of 1 mg/ml (dilution factor between 20-30 times) and incubated for 12 hr at 4 °C. The correctly folding pro-chymosin was activated by acidifying the solution to pH 2.0 with 1.0 M HCl and incubated for 6-8 hr at 20 °C for digesting the pro-peptide. Then, the pH was adjusted to 6.3 by adding 1 M NaOH and it was incubated for second time for an additional 2 hr and the active chymosin was stored at 4 °C.
Enzyme activity measurements:
The milk-clotting activity of the chymosin was determined based on the end-point dilution methods (Emtage et al., 1983) . The substrate was prepared by reconstitute 10 g skim milk in 100 ml phosphate buffer (20 mM KH 2 PO 4 , 10 mM CaCl 2 , pH 5.5) at room temperature (25 °C)and then the skim milk solution was preincubated at 35 °C for 30 min before measurement. The international milk clotting units (IMCU) was calculated by using commercial calf chymosin (1500 IMCU) as standard. One unit was defined as the amount of enzyme necessary to clot 1.0 ml milk at 35 °C in 40 min.
Determination of optimal pH for recombinant chymosin activity:
To identify the optimum pH for recombinant chymosin activity, skim milk powder was reconstitute in either 50 mM acetate buffer (pH 5.0-5.5) or 50 mM potassium phosphate (pH 5.5-6.5) buffer. The clotting activity was measured as mentioned above and the relative activity was plotted against pH.
Determination of optimal temperature for recombinant chymosin activity:
The optimum temperature was determined after incubating both enzyme and substrate solutions (skim milk powder 10% in 20 mM KH 2 PO 4 , 10 mM CaCl 2 , pH 5.5) at different temperature ranging from 40 °C to 65 °C for 10 min. Afterwards, the enzyme solution was added and gently mixed with substrate and incubated at the selected temperature to measure the clotting activity.
SDS-PAGE analysis:
SDS-PAGE was performed with 12% polyacrylamide gel to separate proteins of the whole cell extract, cell free extract, and inclusion bodies in the presence of pre-stained marker (10-250 kDa). To visualize the protein bands, Coomassie brilliant blue (G-250) was used to stain the gels (Laemmli, 1970) .
RESULTS AND DISCUSSION
Construction of the camel pro-chymosin gene and expression plasmid:
The amino acids sequence of camel pro-chymosin protein (Fig.1) was obtained from the online database. The encoding codon for this protein was optimized to facilitate maximum expression in E. coli. The optimum codon encoding for camel pro-chymosin gene (pro.chym, 1101 base pair) was in vitro synthesized and inserted in a bacterial cloning vector (pE-Entry). After plasmid extraction, the pE-pro.chym plasmid was sequenced to identify the inserted fragment (Fig. 2) . The correct plasmid was used further for sub-cloning into expression vector directly downstream E. coli strong tet-promoter. The resulting plasmid, pASG-pro.chym, had a 4263 bp (Fig.3.A) which was appeared as a strong band on gel electrophoresis after digestion with HindIII/ or SacI restriction enzyme (Fig.3.B) . The transformed E. coli BL21 (DE3) with pASG-pro.chym plasmid was further analyzed with colonies PCR-screening using internal vector-based-primers (Seq.F and Seq.R) which produced a 1304 bp fragment (Fig.3.C) . The correct colony carrying the pASG-pro.chym plasmid should produce a 1304 bp fragment (Fig.3.D) . Heterologous expression of the pro-chymosin gene in E. coli: Correct E. coli BL21 (DE3) colonies carrying pASG-pro.chym plasmid were tested for pro-chymosin expression. Cells were grown in LB-media supplemented with ampicillin (100 µg/mL) and induced with 200 ng/mL anhydrotetracycline when the OD 578 was 0.4. Biomass was harvested before induction and 2 hr post-induction. Cellular extracts were subjected to electrophoresis on 12% SDS-polyacrylamide gel (Fig.4) . Obtained result from the analysis of pro-chymosin by SDS-PAGE (Fig.4) revealed that pro-chymosin (367 amino acid residue) was visualized as a sick band. Also its protein had a molecular weight with about 41 kDa, which it is almost similar to the calculated molecular weight (40.6 kDa) as well as the previously reported molecular weight (Kappeler et al., 2007; Langholm Jensen et al., 2013 and Wang et al., 2015) . Further analysis of the produced pro-chymosin band using LabWork3.0 indicating that the amount of recombinant protein was 250 mg/L and it was comparable with that reported before for recombinant bovine chymosin (Menzella, 2011) . The reported expression level of E. coli BL21 (DE3) for recombinant bovine chymosin after 5 hr post-induction was ranged from 260 for the wild type sequence to 450 mg/L after codon optimization (Menzella, 2011) . Since the sequence was optimized, it should produce the highest level but the presented data (250 mg/L) was only after 2 hr post-induction which make it comparable with the previously reported data (Menzella, 2011) . 
Solubilization and renaturation of recombinant prochymosin:
Recombinant pro-chymosin is expressed in bacteria in insoluble form and it is presented in the inclusion bodies. This finding has been reported for the production of recombinant bovine chymosin in E. coli (Mule et al., 2009; El-Sohaimy et al., 2010 and Menzella, 2011) . The recombinant camel chymosin behaves like the bovine one that is presented in inclusion bodies and is not presented in the cell free extract (Fig. 5) . The protein is completely soluble in the solubilizing solution which contains 8.0 M urea. After renaturation and subsequently activation, the mature active form of chymosin shows a molecular weight of 35.6 kDa (Fig.5, lane 4 and 5) . It should be noticed that, recombinant camel chymosin expressed in fungus or yeast is glycosylated and the apparent molecular weight is between 38-40 kDa, while after treatment with endoglycosidase, the protein show a band corresponding to a molecular weight of 35-37kDa (Kappeler, 2006; Langholm Jensen et al., 2013 and Wang et al., 2015) . Since bacteria system does not glycosylate protein which is only happen in eukaryote systems, the apparent molecular weight of protein is almost similar to the calculated one. 
Activity measurement of recombinant camel chymosin:
The clotting activity of recombinant camel chymosin obtained from E. coli was compared with commercial calf chymosin in Fig. (6) . Recombinant chymosin without renaturation is not active and required renaturation process for the generation of active clotting enzyme. Furthermore, the active ammonium sulphate precipitated recombinant camel chymosin has doubled the clotting activity of commercial calf chymosin. This indicates that, the enzyme has a 300 IMCU/ ml. Therefore, it could be concluded that biologically active chymosin expressed in fungi (Kappeler, 2006) or yeast (Wang et al., 2015) can be produced in E. coli after solubilization, renaturation, and acidic activation. Although, calf chymosin has been expressed in E. coli and it was active after solubilization, renaturation, and acidic treatment (ElSohaimy et al., 2010 and Menzella, 2011) . Optimal pH for the produced recombinant camel chymosin:
The effect of the substrate pH on the clotting activity of recombinant chymosin was evaluated and the results are presented in Fig. (7) . The recombinant enzyme has a narrow pH-range for its activity. The enzyme shows more than 80% of its relative activity with the pH value of 5.25 and more than 90% of its relative activity when the pH values were 5.5 or 6.0. The highest level of recombinant camel chymosin activity was observed at pH between 5.5 and 6.0 which is also the range of the animal's milk pH. Two different optimum pH values have been reported before for recombinant camel chymosin. The recombinantly produced camel chymosin in Asperigillus niger had an optimum pH of 6.0 (Kappeler, 2006) , while the produced enzyme in Pichia pastoris had an optimum pH value of 5.04 (Wang et al., 2015) . In contrast, recombinant bovine chymosin had a narrow pH-range for its activity between 5.4 to 5.6 (Cardoza et al., 2003; Starovoitova et al., 2006 and Noseda et al., 2013) . Optimal temperature for the produced recombinant camel chymosin: Figure (8) show the effect of temperature on the clotting activity of the recombinant camel chymosin. There was a significant effect of the temperature on the milk clotting activity. The enzyme show maximum activity (100%) when the temperature was in the range of 50-55 °C. When the temperature was changed within 5 °C down or above the optimum range, a significant decrease of the activity was observed and it was reached of 70 and 60% relative activity, respectively. Further increment of temperature had a significant inhibition effect on the activity due to denature the proteins (Wang et al., 2015) . A further decrease in relative activity to reach about 35 and 5% was observed when the temperature was 65 and 70 °C, respectively. These data are in agreement with the previously published data, in which camel chymosin had an optimum temperature of 45-55 (Kappeler, 2006 and Wang et al., 2015) . It is known that, animal source chymosin is temperature sensitive opposite to plant source rennin which is more resistance for high temperature (Gama Salgado et al., 2013 and Li Yuqiu and Qiyun, 2015) . 
Optimal concentration of CaCl 2 :
The effect of CaCl 2 on the clotting activity of the recombinant camel chymosin was studied and the data were plotted in Figure (9 ). Calcium ions has high impact in milk clotting in which it bind with the insoluble peptide derived (Para-casein) from casein hydrolysis and form clot.
The data in Fig. (9) show that, the enzyme required narrow concentration of CaCl 2 for optimum activation. The maximum activity was observed when CaCl 2 concentration was 15-30 mM and less than 90% relative activity was detected when CaCl 2 concentration was 10 or 45 mM. These data were closed with the reported results for recombinant camel chymosin (Wang et al., 2015) and also with the microbial rennin that has optimum CaCl 2 concentration of 50 mM (Foda, 2012) . 
CONCLUSION
In this work, recombinant camel pro-chymosin was successfully constructed and expressed in E. coli BL21 under tet-promoter. The protein was produced in an insoluble form. It was in vitro solubilized, re-folded from the inclusion bodies, and activated under acidic conditions.
The optimum milk-clotting activity conditions for mature camel chymosin were pH of 5.75, temperature between 50-55 °C, and 15 mM of CaCl 2 . The produced recombinant chymosin could serve as an economic alternative source to bovine chymosin in cheese manufacturing. This study provide that, it is possible to obtain an active mature camel chymosin from E. coli as a first step for large-scale production of recombinant enzyme to meet the needs of local market and maintain the foreign currency.
